Conmed (CNMD) Equity Average (2016 - 2025)
Conmed (CNMD) has disclosed Equity Average for 15 consecutive years, with $1.0 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Average rose 7.69% year-over-year to $1.0 billion, compared with a TTM value of $1.0 billion through Dec 2025, up 7.69%, and an annual FY2025 reading of $997.9 million, up 11.07% over the prior year.
- Equity Average was $1.0 billion for Q4 2025 at Conmed, up from $1.0 billion in the prior quarter.
- Across five years, Equity Average topped out at $1.0 billion in Q4 2025 and bottomed at $694.7 million in Q3 2022.
- Average Equity Average over 5 years is $829.5 million, with a median of $787.8 million recorded in 2022.
- The sharpest move saw Equity Average dropped 7.39% in 2022, then rose 16.26% in 2024.
- Year by year, Equity Average stood at $770.6 million in 2021, then fell by 5.14% to $730.9 million in 2022, then increased by 11.53% to $815.2 million in 2023, then rose by 16.26% to $947.8 million in 2024, then grew by 7.69% to $1.0 billion in 2025.
- Business Quant data shows Equity Average for CNMD at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $990.3 million in Q2 2025.